Computerized Guideline in Heart Failure: Implementation Process and Impact Evaluation
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Objective: To assess the effectiveness of implementation process of an electronic Heart Failure guideline in primary care in the city of Barcelona.
| Condition |
|---|
|
Chronic Heart Failure |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Implementation Process and Impact of the Heart Failure Electronic Clinical Guideline in the Catalan Health Institute Primary Care Health Board |
- ACE/ARBs, ACE/ARBs+BB, hospitalisation rates, survival rate, reliability/ usability/applicability of computerised guideline, economic measurements [ Time Frame: 2005 to 2007 ] [ Designated as safety issue: No ]
| Enrollment: | 13008 |
| Study Start Date: | November 2007 |
| Study Completion Date: | November 2011 |
| Primary Completion Date: | November 2011 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
1 control group
Computerized data collection of outcome measures in usual care
|
|
2 intervention group
Computerized data collection of outcome measures and interviews to clinicians which are using a computerized Heart Failure guideline in their daily practice.
|
Detailed Description:
Design: Two types of design will be applied, according to the specific aims. On the one hand it is a cross-sectional and a qualitative study, on the other hand it is quasi-experimental study. Pre-post intervention with a control group, as well as, of repeated measures in the intervention group
Eligibility| Ages Eligible for Study: | 30 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Setting: 20 general practices in Barcelona (intervention group),with an assigned population of 558515 inhabitants and Girona (control Group) with 23 general practices, and an assigned population of 480827.In 2007, the intervention region had a rate of 1499 patients per GP and from 16 to 52 thousand listed patients per practice with and average of attending rate of 68%, and the control region had a rate of 1558 patients per GP and from 4 to 47 thousand listed patients per practice with and average of attending rate of 76%.
Subjects: Managers and general and nurse practitioners from Barcelona and Girona primary care practices included in the study. Patients with diagnoses related to Heart Failure.
Inclusion Criteria:
- general and nurse primary care practitioners working in Barcelona and Girona for the Health Catalan Institute.
- Managers involved in implementation process for the computerised clinical guideline in Barcelona from the Health Catalan Institute.
- patients with diagnoses of Heart Failure according to ICD-10 according to general practice clinical records.
Exclusion Criteria:
- Managers and general and nurse primary care practitioners working in Barcelona health Centres where there were any other quality improvement project related to Heart failure at the time of the intervention which we are evaluating. Managers from the control group (Girona).
- patients with a mental health disorder or terminal illness
Contacts and Locations| Spain | |
| Unitat de Suport a la Recerca | |
| Barcelona, Spain, 08006 | |
| Principal Investigator: | Josep M Davins, MD, PhD | Unitat de Suport a la Recerca, Barcelona, Spain |
| Study Director: | Eva Frigola, Masters | Unitat de Suport a la Recerca, Barcelona, Spain |
More Information
No publications provided
| Responsible Party: | Jordi Gol i Gurina Foundation |
| ClinicalTrials.gov Identifier: | NCT00792402 History of Changes |
| Other Study ID Numbers: | PI07/91020 |
| Study First Received: | November 17, 2008 |
| Last Updated: | November 22, 2011 |
| Health Authority: | Spain: Ministry of Health |
Keywords provided by Jordi Gol i Gurina Foundation:
|
chronic heart failure Computerized clinical guidelines Primary care |
Additional relevant MeSH terms:
|
Heart Failure Heart Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 19, 2013